Beckmann Nicolau, Falk Regina, Zurbrügg Stefan, Dawson Janet, Engelhardt Petra
Central Technologies, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Magn Reson Med. 2003 Jun;49(6):1047-55. doi: 10.1002/mrm.10480.
Three-dimensional (3D) MR images were obtained from the knees of rats in a model of antigen-induced arthritis, elicited by the intraarticular administration of methylated bovine serum albumin (mBSA) to previously immunized rats. Superparamagnetic particles of iron oxide (SPIO) were administered i.v. 24 hr before each imaging session. Starting 4 days postantigen injection, images from arthritic knees exhibited distinctive signal attenuation in the synovium. This signal attenuation was significantly smaller in knees from animals treated with dexamethasone, a glucocorticosteroid, and completely absent in contralateral knees that had been challenged with vehicle. A significant negative correlation was found between the MRI signal intensity in the synovium and the histologically determined iron content in macrophages located in the same region. These results suggest the feasibility of detecting macrophage infiltration into the knee synovium in this model of antigen-induced arthritis by labeling the cells with SPIO. This readout could provide an early marker of disease progression, before more aggressive changes like cartilage and bone erosion take place. Monitoring early changes associated with arthritis can have an impact in preclinical studies by shortening the duration of the experimental period and by facilitating the investigation of novel immunomodulatory therapies acting on macrophages. Also, the approach can be potentially adapted to clinical studies.
通过向预先免疫的大鼠关节内注射甲基化牛血清白蛋白(mBSA)诱发抗原诱导性关节炎模型,获取大鼠膝关节的三维(3D)磁共振图像。在每次成像前24小时静脉注射超顺磁性氧化铁(SPIO)颗粒。从抗原注射后第4天开始,关节炎膝关节的图像显示滑膜有明显的信号衰减。在用糖皮质激素地塞米松治疗的动物膝关节中,这种信号衰减明显较小,而在注射赋形剂的对侧膝关节中则完全没有。在滑膜的MRI信号强度与位于同一区域的巨噬细胞中组织学测定的铁含量之间发现了显著的负相关。这些结果表明,在该抗原诱导性关节炎模型中,通过用SPIO标记细胞来检测巨噬细胞浸润到膝关节滑膜中的可行性。在软骨和骨侵蚀等更具侵袭性的变化发生之前,这种读数可以提供疾病进展的早期标志物。监测与关节炎相关的早期变化可以通过缩短实验周期和促进对作用于巨噬细胞的新型免疫调节疗法的研究,对临床前研究产生影响。此外,该方法有可能应用于临床研究。